Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Estrogen and heart disease

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    The government funding prospective study of the safety and efficacy of hormone replacement therapy in the menopause practically stopped the routine prescription of estrogen overnight. Why? Our guest today is Dr. Richard Karas, Professor of Medicine, at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard.
Recommended
Details
Presenters
Comments
  • Overview

    The government funding prospective study of the safety and efficacy of hormone replacement therapy in the menopause practically stopped the routine prescription of estrogen overnight. Why? Our guest today is Dr. Richard Karas, Professor of Medicine, at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard.
Schedule22 Oct 2024